| Developers: | Binnopharm Group, Obolenskoye FP ZAO (Alium) |
| Date of the premiere of the system: | 2022/07/28 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
Main article: Antibiotics
2022: Launch of Alfaxim
On July 28, 2022 the Russian pharmaceutical , the company "" Binnopharm Group(part of AFK Sistema) announced the launch of the drug Alfaksim on the market.
According to company representatives, this is the first Russian-made drug with the active ingredient rifaximin. The drug is produced at the company's production site near Moscow - the Alium plant.
As of 2022, in Russia, according to various data, more than 11 million patients are in need of a modern antibacterial drug for the treatment of digestive diseases.
 | "We became the first Russian company to bring rifaximin to the market, making this modern antibiotic more accessible to the consumer and reducing the dependence of patients on the supply of a foreign product," said Rustem Muratov, CEO of Binnopharm Group. - Gastroenterology is one of the key areas in the company's portfolio. As of July 2022, it has more than 20 prescription and over-the-counter drugs. We are interested in this market, and we plan to increase our presence on it. Also, with the advent of the drug [Alfaksim - editor's note Zdrav.Expert], we continue to strengthen the company's position in the important segment of antibiotics for us. " |  |
The gastroenterological portfolio of Binnopharm Group includes the antispasmodic agent with the prokinetic effect Neobutin, the gastroprotector Gastrostat, the hepatoprotector Urdox, as well as other drugs that solve the issues of prevention and treatment of diseases of the gastrointestinal tract, liver and gallbladder.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |